Results 231 to 240 of about 86,262 (260)
Some of the next articles are maybe not open access.
Immune Thrombocytopenia in Lymphoproliferative Disorders
Hematology/Oncology Clinics of North America, 2009Lymphoproliferative disorders are recognized as a common cause of secondary immune thrombocytopenia (ITP). The mechanisms involved in the pathogenesis of ITP associated with lymphoproliferative disorders are heterogeneous and often linked to the presence and activity of the malignant clone.
Visco, Carlo, Rodeghiero, Francesco
openaire +2 more sources
Pediatric Immune Thrombocytopenia
Advances in PediatricsPediatric immune thrombocytopenia (ITP) is a fairly common bleeding disorder PRESENTING with a decreased number of platelets. The typical clinical presentation involves mild bleeding symptoms with bruising and petechiae and occasional mucosal bleeding.
Moran, Gotesman +4 more
openaire +2 more sources
New England Journal of Medicine, 2020
Virinder, Nohria, A Christopher, Macie
openaire +2 more sources
Virinder, Nohria, A Christopher, Macie
openaire +2 more sources
Rilzabrutinib in Immune Thrombocytopenia
New England Journal of Medicine, 2022Jun, Murakami +2 more
openaire +2 more sources
Rilzabrutinib for immune thrombocytopenia
Nature Cardiovascular Research, 2022openaire +2 more sources
1996
Abstract Hematologic abnormalities commonly occur among HIV-infected patients, usually reflecting either myelosuppression or hypoproliferation of all three cell lines. HIV- associated immune thrombocytopenia (ITP}, which typically results from rapid platelet destruction, is considered an exception to this general principle.
openaire +1 more source
Abstract Hematologic abnormalities commonly occur among HIV-infected patients, usually reflecting either myelosuppression or hypoproliferation of all three cell lines. HIV- associated immune thrombocytopenia (ITP}, which typically results from rapid platelet destruction, is considered an exception to this general principle.
openaire +1 more source
Update on diagnosis and treatment of immune thrombocytopenia
Expert Review of Clinical Pharmacology, 2021Kamalkant Sahu +2 more
exaly
Guidelines for Immune Thrombocytopenia
New England Journal of Medicine, 2011Drew, Provan, Adrian C, Newland
openaire +2 more sources

